These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5008231)

  • 1. Percent uptake of 131-I radioactivity in the adrenal from radioiodinated cholesterol.
    Morita R; Lieberman LM; Beierwaltes WH; Conn JW; Ansari AN; Nishiyama H
    J Clin Endocrinol Metab; 1972 Jan; 34(1):36-43. PubMed ID: 5008231
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical treatment of Cushing's disease.
    N Engl J Med; 1969 Oct; 281(15):846-7. PubMed ID: 5809521
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of o,p'-DDD on cortisol secretory pattern in Cushing's syndrome.
    Hellman L; Weitzman ED; Roffwarg H; Fukushima DK; Yoshida K; Zumoff B; Gallagher TF
    J Clin Endocrinol Metab; 1970 Aug; 31(2):227-30. PubMed ID: 4316529
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of aminoglutethimide on adrenal cholesterol in patients with Cushing's syndrome.
    Felt V
    Endocrinol Exp; 1973; 7(4):293-6. PubMed ID: 4543647
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Cushing's sundrome in the dog with an adrenocorticolytic agent (o,p'DDD).
    Schechter RD; Stabenfeldt GH; Gribble DH; Ling GV
    J Am Vet Med Assoc; 1973 Apr; 162(8):629-39. PubMed ID: 4697358
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Cushing's disease. Correction of hypercortisolism by o,p'DDD without induction of aldosterone deficiency.
    Temple TE; Jones DJ; Liddle GW; Dexter RN
    N Engl J Med; 1969 Oct; 281(15):801-5. PubMed ID: 4309238
    [No Abstract]   [Full Text] [Related]  

  • 7. Remission in Cushing's syndrome with o,p'-DDD.
    Southren AL; Tochimoto S; Strom L; Ratuschni A; Ross H; Gordon G
    J Clin Endocrinol Metab; 1966 Mar; 26(3):268-78. PubMed ID: 4286017
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatty acid composition of the sterol ester fraction of human adrenal cortex in Cushingś syndrome and after treatment with aminoglutethimide.
    Raggatt PR; Engel LL; Symington T
    Lipids; 1972 Jul; 7(7):474-82. PubMed ID: 5049143
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vivo metabolism of 131-I-19-cholesterol used as adrenal gland scanning agent].
    Fukuchi S; Nakajima K; Takenouchi T; Tsuchida S; Ogawa H
    Nihon Naibunpi Gakkai Zasshi; 1973 Oct; 49(10):1245-53. PubMed ID: 4797055
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of a Cushing syndrome caused by hyperplasia of the adrenal cortex in a 7-year old girl with the adrenal cortex blocking agent opDDD ].
    Pichler E
    Helv Paediatr Acta; 1966 Nov; 21(5):447-74. PubMed ID: 5995803
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cushing's syndrome].
    Geyer G
    Ann N Y Acad Sci; 1973 Jun; 214():614-9. PubMed ID: 4593436
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathways of corticosteroid biosynthesis in human adrenals (Itsenko-Cushing disease)].
    Iudaev NA; Afinogenova SA
    Biokhimiia; 1976 Sep; 41(9):1619-27. PubMed ID: 974176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tissue concentrations and in-vitro biosynthesis of corticosteroids in normal and hyperplastic (Cushing) human adrenal glands].
    Sinterhauf K; Herzog P; Diedrichsen G; Lommer D
    Verh Dtsch Ges Inn Med; 1974; 80():1391-4. PubMed ID: 4454433
    [No Abstract]   [Full Text] [Related]  

  • 14. The synthesis of carbon-14 and radioiodinated compounds in the dichlorodiphenyldichloroethane (DDD) series.
    Counsell RE; Willette RE; Diguilio W
    J Nucl Med; 1967 May; 8(5):381. PubMed ID: 6032699
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of metyrapone to inhibit 11-hydroxylation of 11-deoxycortisol during drug therapy.
    Werk EE; Thrasher K; Choi Y; Sholiton LJ
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1358-60. PubMed ID: 4292251
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenocorticotropin measurement by competitive binding receptor assay.
    Wolfsen AR; McIntyre HB; Odell WD
    J Clin Endocrinol Metab; 1972 Apr; 34(4):684-9. PubMed ID: 4335104
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor localizing agents VI. Radioiodinated analogs of dichlorodiphenyldichloroethane (DDD).
    Counsell RE; Ranade VV; Pocha P; Willette RE; DiGuilio W
    J Pharm Sci; 1968 Oct; 57(10):1657-61. PubMed ID: 5684730
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of adrenal cholesterol in man. I. In vivo studies.
    Borkowski A; Delcroix C; Levin S
    J Clin Invest; 1972 Jul; 51(7):1664-78. PubMed ID: 4338119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of treatment in 108 patients with Cushing's syndrome.
    Orth DN; Liddle GW
    N Engl J Med; 1971 Jul; 285(5):243-7. PubMed ID: 4326256
    [No Abstract]   [Full Text] [Related]  

  • 20. [Place of synthetic anticortisolic agents in Cushing's syndrome].
    Bricaire H; Luton JP; Mathieu de Fossey B; Rémy JM
    Therapeutique; 1971 Jan; 47(1):7-10. PubMed ID: 5572923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.